Smith LA - Search Results

1

Botulinum neurotoxin vaccines: Past history and recent developments.

Rusnak JM, Smith LA. Rusnak JM, et al. Among authors: smith la. Hum Vaccin. 2009 Dec;5(12):794-805. doi: 10.4161/hv.9420. Epub 2009 Dec 1. Hum Vaccin. 2009. PMID: 19684478 Review.

2

Botulinum neurotoxin vaccines: past, present, and future.

Smith LA, Rusnak JM. Smith LA, et al. Crit Rev Immunol. 2007;27(4):303-18. doi: 10.1615/critrevimmunol.v27.i4.20. Crit Rev Immunol. 2007. PMID: 18197811 Review.

3

Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.

Dembek ZF, Smith LA, Rusnak JM. Dembek ZF, et al. Among authors: smith la. Disaster Med Public Health Prep. 2007 Nov;1(2):122-34. doi: 10.1097/DMP.0b013e318158c5fd. Disaster Med Public Health Prep. 2007. PMID: 18388640 Review.

4

Botulism and vaccines for its prevention.

Smith LA. Smith LA. Vaccine. 2009 Nov 5;27 Suppl 4:D33-9. doi: 10.1016/j.vaccine.2009.08.059. Vaccine. 2009. PMID: 19837283 Review.

5

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.

Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC. Webb RP, et al. Among authors: smith tj, smith la. Toxins (Basel). 2017 Sep 3;9(9):269. doi: 10.3390/toxins9090269. Toxins (Basel). 2017. PMID: 28869522 Free PMC article.

6

Roads from vaccines to therapies.

Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. Smith LA, et al. Among authors: smith tj. Mov Disord. 2004 Mar;19 Suppl 8:S48-52. doi: 10.1002/mds.20009. Mov Disord. 2004. PMID: 15027054

7

Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey.

Boles J, West M, Montgomery V, Tammariello R, Pitt ML, Gibbs P, Smith L, LeClaire RD. Boles J, et al. Toxicon. 2006 Jun 15;47(8):877-84. doi: 10.1016/j.toxicon.2006.02.013. Epub 2006 Mar 24. Toxicon. 2006. PMID: 16730042

8

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

Lee JS, Groebner JL, Hadjipanayis AG, Negley DL, Schmaljohn AL, Welkos SL, Smith LA, Smith JF. Lee JS, et al. Among authors: smith jf, smith la. Vaccine. 2006 Nov 17;24(47-48):6886-92. doi: 10.1016/j.vaccine.2006.06.004. Epub 2006 Jun 21. Vaccine. 2006. PMID: 16828936

9

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.

Lee JS, Pushko P, Parker MD, Dertzbaugh MT, Smith LA, Smith JF. Lee JS, et al. Among authors: smith jf, smith la. Infect Immun. 2001 Sep;69(9):5709-15. doi: 10.1128/IAI.69.9.5709-5715.2001. Infect Immun. 2001. PMID: 11500447 Free PMC article.

10

What next for botulism vaccine development?

Webb RP, Smith LA. Webb RP, et al. Among authors: smith la. Expert Rev Vaccines. 2013 May;12(5):481-92. doi: 10.1586/erv.13.37. Expert Rev Vaccines. 2013. PMID: 23659297 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

739 results

Search Page